IL145835A0 - Expression products of genes involved in diseases related to cholesterol metabolism - Google Patents

Expression products of genes involved in diseases related to cholesterol metabolism

Info

Publication number
IL145835A0
IL145835A0 IL14583500A IL14583500A IL145835A0 IL 145835 A0 IL145835 A0 IL 145835A0 IL 14583500 A IL14583500 A IL 14583500A IL 14583500 A IL14583500 A IL 14583500A IL 145835 A0 IL145835 A0 IL 145835A0
Authority
IL
Israel
Prior art keywords
genes involved
diseases related
expression products
cholesterol metabolism
cholesterol
Prior art date
Application number
IL14583500A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9906587A external-priority patent/FR2794131B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL145835A0 publication Critical patent/IL145835A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL14583500A 1999-05-25 2000-05-25 Expression products of genes involved in diseases related to cholesterol metabolism IL145835A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9906587A FR2794131B1 (fr) 1999-05-25 1999-05-25 Produits d'expression de genes impliques dans des affections associees au metabolisme du cholesterol
US13945099P 1999-06-16 1999-06-16
PCT/FR2000/001426 WO2000071710A2 (fr) 1999-05-25 2000-05-25 Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol

Publications (1)

Publication Number Publication Date
IL145835A0 true IL145835A0 (en) 2002-07-25

Family

ID=26234967

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14583500A IL145835A0 (en) 1999-05-25 2000-05-25 Expression products of genes involved in diseases related to cholesterol metabolism

Country Status (11)

Country Link
EP (1) EP1183350A2 (hu)
JP (1) JP2003518918A (hu)
KR (1) KR20020033627A (hu)
AU (1) AU4931800A (hu)
BR (1) BR0010916A (hu)
CA (1) CA2371500A1 (hu)
HU (1) HUP0203164A2 (hu)
IL (1) IL145835A0 (hu)
MX (1) MXPA01011882A (hu)
NO (1) NO20015729L (hu)
WO (1) WO2000071710A2 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000055318A2 (en) 1999-03-15 2000-09-21 University Of British Columbia Abc1 polypeptide and methods and reagents for modulating cholesterol levels
WO2002010388A2 (en) * 2000-08-01 2002-02-07 Amgen Inc. C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
AT413701B (de) * 2001-11-06 2006-05-15 Bmt Medizinische Forschung Und Strukturelle und funktionelle charakterisierung von cdw92
WO2008081942A1 (ja) 2007-01-05 2008-07-10 The University Of Tokyo 抗prg-3抗体を用いる癌の診断および治療
CN102112492B (zh) 2007-11-14 2015-02-25 中外制药株式会社 使用抗gpr49抗体的癌症的诊断和治疗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020165A2 (en) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Biallelic markers

Also Published As

Publication number Publication date
WO2000071710A3 (fr) 2001-05-17
NO20015729D0 (no) 2001-11-23
MXPA01011882A (es) 2002-05-06
NO20015729L (no) 2002-01-22
KR20020033627A (ko) 2002-05-07
HUP0203164A2 (hu) 2002-12-28
EP1183350A2 (fr) 2002-03-06
WO2000071710A2 (fr) 2000-11-30
CA2371500A1 (fr) 2000-11-30
BR0010916A (pt) 2002-02-19
JP2003518918A (ja) 2003-06-17
AU4931800A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
GB2361568B (en) Improvements in or relating to packaging/display of products
PL316200A1 (en) Co-ordinated expression of genes in vivo
AU2001285047A1 (en) Human genes and gene expression products
AP2000001762A0 (en) Method of delivering genes to antigen presenting cells of the skin
AU2001238511A1 (en) Cosmetics to support skin metabolism
AU5319499A (en) Fatty acids to minimize cancer therapy side effects
EP1276754A4 (en) MATERIALS AND METHODS RELATING TO LIPID METABOLISM
GB0014150D0 (en) Improvements relating to computer graphics
IL145835A0 (en) Expression products of genes involved in diseases related to cholesterol metabolism
AU2002219988A1 (en) Compositions and methods relating to breast specific genes and proteins
AU2001244892A1 (en) Improvements in and relating to honey based products
AU4329300A (en) Human mesenchymal dnas and expression products
IL146237A0 (en) Autotaxin variants and uses to treat diseases of metabolism
ZA200109129B (en) Expression products of genes involved in diseases related to cholesterol metabolism.
AU2003252979A1 (en) Improvements in or relating to the heating of products
GB9910139D0 (en) Improvements in and relating to fermented meat products
AU1520599A (en) Somatic transfer of modified genes to predict drug effects
HK1045103A1 (zh) Bpi蛋白質產品於bpi蛋白質不足的人體的治療用途
IL147071A0 (en) Nucleic and proteinic acids corresponding to human gene abc1
AU1576501A (en) Methods to enhance and confine gene expression in cancer therapy
AU2352301A (en) Gene expression in corneal diseases
GB9906537D0 (en) Improvements relating to products displays
IL145056A0 (en) Expression of human alpha-fetoprotein in mammalian cells
AU2001297804A1 (en) Compositions and methods relating to breast specific genes and proteins
AU6181400A (en) Gene expressed specifically in human fetal heart muscle